Top Markets
Coin of the day
Tetra Bio-Pharma Inc. Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Inc.

TBP
Rangering i aksjer #35576
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
Aksjekurs
$0.01851783
Sist synkronisert: 2023-05-23
Markedsverdi
$3.71M
Endring (1 dag)
-0.04%
Endring (1 år)
0.00%
Land
CA
Handel Tetra Bio-Pharma Inc. (TBP)

Kategori

P/B-forhold for Tetra Bio-Pharma Inc. (TBP)
P/B-forhold per 2026 TTM: 0
Ifølge Tetra Bio-Pharma Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Tetra Bio-Pharma Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.3419 -
US
6.2413 -
NL
- -
CH
- -
KR
3.4612 -
BE